par Ledent, Catherine 
;Coppee, Frédérique ;Dumont, Jacques Emile ;Vassart, Gilbert ;Parmentier, Marc
Référence Experimental and clinical endocrinology & diabetes, 104 Suppl 3, page (43-46)
Publication Publié, 1996
;Coppee, Frédérique ;Dumont, Jacques Emile ;Vassart, Gilbert ;Parmentier, Marc Référence Experimental and clinical endocrinology & diabetes, 104 Suppl 3, page (43-46)
Publication Publié, 1996
Article révisé par les pairs
| Résumé : | Mouse transgenic models that develop thyroid diseases were generated. All transgenes were driven by the thyroid specific promoter of the thyroglobulin gene. The tissue specificity of the promoter was investigated by using the bacterial chloramphenicol acetyl transferase gene as reporter. The expression of an adenosine A2a receptor resulted in the permanent activation of the cAMP cascade. As a consequence, the transgenic mice developed severe hyperthyroidism and a large goiter, demonstrating in vivo the role of the cAMP cascade in the promotion of both function and proliferation of the thyroid cell. These mice constitute a model for autonomous hyperfunctional adenoma and non-autoimmune familial hyperthyroidism, where mutant thyrotropin receptors stimulate the cAMP cascade constitutively. In another transgenic model, the function of the retinoblastoma susceptibility gene product RB1 (and of related proteins) was inhibited by expression of the E7 oncoprotein of human papillomavirus type 16. The result was the development of a differentiated and normofunctional colloid goiter, with the progressive development of differentiated malignant lesions. This model suggests the essential role of RB1 and related proteins in the negative control of proliferation that characterizes thyroid cells in the adult. Other transgenic models of thyroid diseases are discussed. |
